- Home
- TRST vs KALV Comparison
TRST vs KALV Comparison
Compare TRST & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- KALV
- Stock Information
- Founded
- TRST 1902
- KALV N/A
- Country
- TRST United States
- KALV United States
- Employees
- TRST N/A
- KALV N/A
- Industry
- TRST Major Banks
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- TRST Finance
- KALV Health Care
- Exchange
- TRST Nasdaq
- KALV Nasdaq
- Market Cap
- TRST 755.5M
- KALV 796.4M
- IPO Year
- TRST N/A
- KALV N/A
- Fundamental
- Price
- TRST $39.16
- KALV $13.62
- Analyst Decision
- TRST
- KALV Strong Buy
- Analyst Count
- TRST 0
- KALV 8
- Target Price
- TRST N/A
- KALV $26.43
- AVG Volume (30 Days)
- TRST 135.2K
- KALV 986.2K
- Earning Date
- TRST 10-20-2025
- KALV 09-11-2025
- Dividend Yield
- TRST 3.64%
- KALV N/A
- EPS Growth
- TRST 8.63
- KALV N/A
- EPS
- TRST 2.81
- KALV N/A
- Revenue
- TRST $177,008,000.00
- KALV $1,426,000.00
- Revenue This Year
- TRST $13.13
- KALV N/A
- Revenue Next Year
- TRST N/A
- KALV $221.95
- P/E Ratio
- TRST $14.08
- KALV N/A
- Revenue Growth
- TRST 2.80
- KALV N/A
- 52 Week Low
- TRST $27.18
- KALV $7.30
- 52 Week High
- TRST $40.96
- KALV $17.28
- Technical
- Relative Strength Index (RSI)
- TRST 59.97
- KALV 45.29
- Support Level
- TRST $38.85
- KALV $13.26
- Resistance Level
- TRST $40.19
- KALV $17.28
- Average True Range (ATR)
- TRST 0.91
- KALV 1.00
- MACD
- TRST -0.15
- KALV -0.02
- Stochastic Oscillator
- TRST 40.59
- KALV 16.44
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.